These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 17876303)

  • 1. The complications of promiscuity: endocannabinoid action and metabolism.
    Alexander SP; Kendall DA
    Br J Pharmacol; 2007 Nov; 152(5):602-23. PubMed ID: 17876303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.
    Brunt TM; Bossong MG
    Eur J Neurosci; 2022 Feb; 55(4):909-921. PubMed ID: 32974975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
    Reggio PH
    Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: a general view and latest additions.
    De Petrocellis L; Cascio MG; Di Marzo V
    Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel natural and synthetic ligands of the endocannabinoid system.
    Hanus LO; Mechoulam R
    Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medicinal chemistry of endocannabinoid system 25 Jan.
    Nevalainen T; Minkkilä A
    Curr Top Med Chem; 2010; 10(8):767. PubMed ID: 20482503
    [No Abstract]   [Full Text] [Related]  

  • 7. The Endocannabinoid System and its Modulation by Phytocannabinoids.
    Di Marzo V; Piscitelli F
    Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.
    Fowler CJ
    Br J Pharmacol; 2007 Nov; 152(5):594-601. PubMed ID: 17618306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
    Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
    Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids, endocannabinoids, and cancer.
    Hermanson DJ; Marnett LJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
    Karanian DA; Bahr BA
    Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the endocannabinoid system in treating brain disorders.
    Bahr BA; Karanian DA; Makanji SS; Makriyannis A
    Expert Opin Investig Drugs; 2006 Apr; 15(4):351-65. PubMed ID: 16548785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
    Saito VM; Wotjak CT; Moreira FA
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S7-14. PubMed ID: 20512266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system and the treatment of mood and anxiety disorders.
    Hill MN; Gorzalka BB
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):451-8. PubMed ID: 19839936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview.
    Barna I; Zelena D
    Endocr Regul; 2012 Apr; 46(2):107-24. PubMed ID: 22540859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events.
    Sun X; Dey SK
    Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.
    Pertwee RG
    AAPS J; 2005 Oct; 7(3):E625-54. PubMed ID: 16353941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid signaling in microglial cells.
    Stella N
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):244-53. PubMed ID: 18722389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.
    Giuffrida A; McMahon LR
    Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.